11-hydroxy-N-(n-propyl)noraporphine
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m (1 revision) |
(→External Links) |
||
| (2 intermediate revisions not shown.) | |||
| Line 24: | Line 24: | ||
==Description== | ==Description== | ||
| - | RN given refers to parent cpd without isomeric designation; (R)-isomer is a dopamine agonist; (S)-isomer is a dopamine antagonist | + | |
| + | RN given refers to parent cpd without isomeric designation; (R)-isomer is a dopamine agonist; (S)-isomer is a dopamine antagonist. | ||
==General Properties== | ==General Properties== | ||
| Line 60: | Line 61: | ||
[http://crdd.osdd.net/raghava/biadb/detail.php?id=1110 Link to BIAdb Database] | [http://crdd.osdd.net/raghava/biadb/detail.php?id=1110 Link to BIAdb Database] | ||
| + | [[Category:BIAdb_old]] | ||
Current revision
| 11-hydroxy-N-(n-propyl)noraporphine
| |
| Systematic (IUPAC) name | |
| N/A | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H21NO |
| Mol. mass | 279.37614 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
RN given refers to parent cpd without isomeric designation; (R)-isomer is a dopamine agonist; (S)-isomer is a dopamine antagonist.
[edit] General Properties
*Molecular Weight
279.37614
*Molecular Formula
C19H21NO
*IUPAC NAME
N/A
*Canonical Smiles
CCCN1CCC2=CC=CC3=C2C1CC4=C3C(=CC=C4)O
*Isomeric Smiles
N/A
*XLogP
3.9
*Topological Polar Surface Area
23.5
